Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases
Vishakha Singh, Amit Khurana, Prince Allawadhi, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 24

Showing 24 citing articles:

Gene therapy: Comprehensive overview and therapeutic applications
Nilofer Sayed, Prince Allawadhi, Amit Khurana, et al.
Life Sciences (2022) Vol. 294, pp. 120375-120375
Closed Access | Times Cited: 204
PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
Qian Li, Jingjing Han, Yonglin Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 122
PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment
Adil Parvez, Furqan Choudhary, Priyal Mudgal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 77
Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics
Vishakha Singh, Amit Khurana, Umashanker Navik, et al.
Sci (2022) Vol. 4, Iss. 2, pp. 15-15
Open Access | Times Cited: 73
Chronic Hepatitis B Infection: New Approaches towards Cure
Mojisola Ogunnaike, Srijanee Das, Samiksha S. Raut, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1208-1208
Open Access | Times Cited: 19
Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis
Sabira Mohammed, Nidheesh Thadathil, Phoebe Ohene-Marfo, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 9, pp. 933-946
Open Access | Times Cited: 17
Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents
Jin Liu, Yao Cheng, L. Yuan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 13172-13188
Closed Access | Times Cited: 15
A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery
Amit Khurana, Nilofer Sayed, Vishakha Singh, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 10, pp. 1674-1698
Open Access | Times Cited: 17
Navigating through the PD-1/PDL-1 Landscape: A Systematic Review and Meta-Analysis of Clinical Outcomes in Hepatocellular Carcinoma and Their Influence on Immunotherapy and Tumor Microenvironment
Muhammad Joan Ailia, Jeong Heo, So Young Yoo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6495-6495
Open Access | Times Cited: 11
The Important Roles of Natural Killer Cells in Liver Fibrosis
Ming Yang, Ethan Vanderwert, Eric T. Kimchi, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1391-1391
Open Access | Times Cited: 10
A triple-targeting “nano-brake” remodeling the impaired immune microenvironment in skin lesions for psoriasis treatment
Ruijie Chen, B Duan, Shize Li, et al.
Materials Today Bio (2025), pp. 101875-101875
Open Access
Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates
Chengbin Guo, Yuqin Tang, Yang Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Hepatitis-related adverse events associated with immune checkpoint inhibitors in cancer patients: an observational, retrospective, pharmacovigilance study using the FAERS database
Zhiwen Fu, Jinmei Liu, Cong Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression
Yikai Wang, Muqi Wang, Chenrui Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study
Rubén Martín‐Escolano, Ana Virseda‐Berdices, Juan Berenguer, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Human Liver MSCs Retain Their Basic Cellular Properties in Chronically Inflamed Liver Tissue
Yan Kim, А. Yu. Lupatov, V. V. Burunova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13374-13374
Open Access | Times Cited: 1
Possibility of PD-1/PD-L1 Inhibitors for the Treatment of Patients with Chronic Hepatitis B Infection
Menghan Su, Ting Ye, Wei Wu, et al.
Digestive Diseases (2023) Vol. 42, Iss. 1, pp. 53-60
Open Access | Times Cited: 3
Spotlight on liver macrophages for halting liver disease progression and injury
Amit Khurana, Umashanker Navik, Prince Allawadhi, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 8, pp. 707-719
Closed Access | Times Cited: 3
The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
Dali Zhang, Danni Feng, Xi He, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Aspirin attenuates hepatocellular carcinoma progression by inhibiting PD-L1 expression
Yikai Wang, Muqi Wang, C. Liu, et al.
Research Square (Research Square) (2023)
Open Access
Data from Absence of Either <i>Ripk3</i> or <i>Mlkl</i> Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis
Sabira Mohammed, Nidheesh Thadathil, Phoebe Ohene-Marfo, et al.
(2023)
Open Access
Research Progress of PD-1/PD-L1 Inhibitors in Immunotherapy of Prostate Cancer
佳慧 吴
Advances in Clinical Medicine (2023) Vol. 13, Iss. 06, pp. 10496-10504
Closed Access
Data from Absence of Either <i>Ripk3</i> or <i>Mlkl</i> Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis
Sabira Mohammed, Nidheesh Thadathil, Phoebe Ohene-Marfo, et al.
(2023)
Open Access
A Monograph on Antimicrobial Resistance (AMR) and Alternatives Strategies to Counter AMR
Anil Kumar Banothu
Acta Scientific Veterinary Sciences (2022), pp. 95-101
Open Access
Blocking necroptosis reduces inflammation and tumor incidence in a mouse model of diet-induced hepatocellular carcinoma
Sabira Mohammed, Nidheesh Thadathil, Albert L. Tran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top